Increasing choice of and access to family planning services via outreach in Rajasthan, India by Aruldas, Kumudha et al.
Population Council 
Knowledge Commons 
Reproductive Health Social and Behavioral Science Research (SBSR) 
2014 
Increasing choice of and access to family planning services via 
outreach in Rajasthan, India 
Kumudha Aruldas 
Population Council 
M.E. Khan 
Population Council 
Jaleel Ahmad 
Population Council 
Anvita Dixit 
Population Council 
Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh 
 Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society 
Commons, International Public Health Commons, Maternal and Child Health Commons, and the Women's 
Health Commons 
Recommended Citation 
Aruldas, Kumudha, M.E. Khan, Jaleel Ahmad, and Anvita Dixit. 2014. "Increasing choice of and access to 
family planning services via outreach in Rajasthan, India." New Delhi: Population Council. 
This Report is brought to you for free and open access by the Population Council. 
Increasing choice of and access to  
family planning services via outreach  
in Rajasthan, India
An evaluation of Marie Stopes India’s outreach services
Population Council May 2014
 
i Authors and acknowledgements
The Population Council confronts critical health and developmental issues, from stopping the spread of HIV 
to improving reproductive health and ensuring that young people lead full and productive lives. Through 
biomedical, social science, and public health research in 50 countries, we work with our partners to deliver 
solutions that lead to more effective policies, programs, and technologies that improve lives around the 
world. Established In 1952 and headquartered in New York, the Council is a nongovernmental, non-profit 
organization governed by an international board of trustees.  
www.popcouncil.org
This study is made possible by the USAID Support for International Family Planning Organizations 
(SIFPO) project. SIFPO is implemented by MSI in partnership with EngenderHealth, the International 
Center for Research on Women, the International HIV/AIDS Alliance, and Population Council, aims to 
increase the use and availability of voluntary family planning services globally through strengthening MSI’s 
capacity. SIFPO is a five-year program funded by the USAID under Cooperative Agreement No. AID-
OAA-A-10-00059. The contents are the responsibility of the Population Council and do not necessarily 
reflect the views of USAID or the United States Government.
Acknowledgements
The Population Council would like to thank Monisha Vaid, Research and Evaluation Manager along with the 
MSI Rajasthan team for helping to coordinate with the Population Council’s research team, Aziz Rahman 
for data entry and Louise Bury for assisting with the report edit.  
Suggested citation
Aruldas, K., Khan, M. E., Ahmad, J., & Dixit, A., (2014). Increasing choice and access to family planning 
services via outreach in Rajasthan, India: An evaluation of MSI India’s outreach services New Delhi, India: 
Population Council.  
© 2013 The Population Council, Inc
Cover photograph credit 
Marie Stopes International 
© Marie Stopes International
Acronyms
ASHA  Accredited Social Health Activist
ANM  Auxiliary Nurse and Midwife
AWW   Anganwadi Worker
CHC   Community Health Center
CHW   Community Health Worker
COT  Clinical outreach teams
CPR  Contraceptive Prevalence Rate
FP  Family PlanningSciences
GOI  Government of India
IPC  Interpersonal Communicator
IUD  Intra Uterine Contraceptive Device
LAPM  Long-acting and permanent method
MSI  Marie Stopes International
NPP  National Population Policy
PHC  Primary Health Center
OBC   Other Backward Classes
SIFPO  Supporting International Family Planning 
  Organizations
SLI  Standard of Living Index
SRH  Sexual and reproductive health
SPSS  Statistical Package for the Social 
Sciences
TL  Tubal Ligation
USAID United States Agency for International 
Development
iiContents
Contents
1.  Executive summary iii
2. Introduction 01
 2.1  Family planning method mix in India  01
 2.2  Access to family planning services 02
 2.3  Marie Stopes India 02
 2.4 Study aims and objectives 04
3. Methodology 05
 3.1 Study design, location and participants  05
4. Findings 07
 4.1 Study recruitment  07
 4.2 Socio demographic characteristics  07
 4.3 Knowledge and source of information about contraception  10
 4.4 Previous contraceptive use  10
 4.5 Source of information about outreach services and decision making  10
 4.6 Side effects and incidence of complications  11
 4.7 Follow up care and health seeking behaviour by day 15  14
 4.8 IUD discontinuation by day 90 post procedure  15
 4.9 Client Satisfaction   17
 
5. Discussion and recommendations 18
 5.1 Conclusions 20
 5.2 Recommendations 20
 5.3 Evidence to Action: Marie Stopes India response to recommendations 21
6. References 22
List of tables 
 Table 1: Family planning data for Rajasthan State and India 01
 Table 2: Severity level of side effects 06
 Table 3: Distribution of TL and IUD clients recruited for the study by district 08
 Table 4: Client socio-demographic characteristics for TL and IUD services 09
 Table 5: Types of side effects and severity reported by clients post procedure 12
 Table 6: Types of side effects / complications and severity reported by TL clients  
 15 days post procedure (n=803) 13
 Table 7: Types of side effects / complications and severity reported by IUD clients 
 15 days post procedure (n=369) 14
 Table 8: Health seeking behaviour among women up to day 15 following TL and IUD procedure 15
List of figures 
 Figure 1: Study cohort profile 08
 Figure 2: Reasons cited for choosing MSI outreach services IUD / TL (% of women) 10
 Figure 3: Reasons cited by clients for adopting tubal ligation and IUD –  
 multiple answers given (% of women) 11 
 Figure 4: Flow chart showing IUD discontinuation by day 90 among IUD study cohort 16 
 Figure 5: Self reporting of continued side effects of IUD at day 90 (% of women) (n=393) 16
iii Executive summary
This report documents a service evaluation of Marie 
Stopes (MS) India’s mobile outreach programme in the 
state of Rajasthan, which was conducted by the 
Population Council in India between March and 
October 2012. This study was made possible through 
the United States Agency for International 
Development (USAID) funded Support for International 
Family Planning Organizations - Marie Stopes 
International (SIFPO-MSI) project. It provides 
important findings on the safety and effectiveness of 
MS India’s outreach programme in expanding choice 
and access to long-acting reversible contraception 
(LARC) methods and voluntary surgical permanent 
methods (PM) of contraception, as well as 
recommendations for MS India and other family 
planning programmes to consider in scaling up and 
strengthening provision of mobile outreach services.  
Family planning in India 
India has a modern contraceptive prevalence rate of 
48% [2]. One in five married women has an unmet 
need for family planning; 13% of married women have 
an unmet need for contraception to limit childbearing, 
while 7% of married women have an unmet need for 
spacing [12]. Unmet need is more acute in rural 
settings where health services and personnel are 
lacking. To address this, in recent decades the 
Government of India (GOI) has focused on expanding 
access to voluntary Family planning services. This was 
most recently articulated in the National Population 
Policy (NPP 2000), which emphasises the need to 
continue to provide reproductive healthcare and family 
planning services using a voluntary, informed consent 
and target-free approach. NPP 2000 has been 
bolstered by GOI strategies aimed at reducing the cost 
burden of family planning services, in particular costs 
and barriers associated with higher-cost permanent 
methods.
The family planning method mix in India remains 
dominated by voluntary permanent methods. Currently, 
nearly three quarters (71%) of modern method family 
planning users in India have opted for female 
sterilisation. Despite high levels of effectiveness and 
user satisfaction [3], LARC uptake is very low, with 
only 2% of women using the intrauterine device (IUD). 
The contraceptive implant is not yet registered in India; 
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therefore, use of LARC is limited to IUDs. A lack of 
access to and uptake of LARC stems from weak 
political support, prevailing misconceptions amongst 
potential users, and poor provider counselling. 
Contraceptive injectables are available in private 
sector facilities but are not offered in the public sector 
where short-acting methods are limited to oral 
contraceptive pills and condoms. Emergency 
contraception is also available. In India, uptake of 
condoms stands at 6% and uptake of pills at 4% [12]. 
Permanent methods for males (vasectomy) represent 
approximately 1% of modern method use [12].  
Despite a decline in the country’s total fertility rate 
(TFR), this has not translated to improved maternal 
and infant health, partly due to early marriage and 
short intervals between births. In order to improve 
women’s health and enable couples to achieve desired 
family size, it is crucial to improve current low 
contraceptive access and limited choice among family 
planning methods, particularly in rural and poor 
regions of India. 
Marie Stopes India 
Marie Stopes India was established in 2008 to work in 
partnership with the GOI health departments to 
provide reproductive health and family planning 
services to poor men and women living in rural and 
remote areas. Partnership with non-governmental 
service providers is a key strategic approach for GOI 
implementation of frameworks such as the National 
Population Policy (NPP 2000). 
Although the GOI offers family planning services 
through public sector facilities and has been active 
delivering permanent methods through outreach, GOI 
capacity is limited and, therefore, significant demand 
for PMs and LARC in rural districts remains unmet. 
The private (commercial) health sector in India is 
active, yet scarcity of private clinics in rural regions 
somewhat limits the private sector’s role in service 
delivery to the hardest to reach and poorest clients. 
Through collaboration with the GOI to provide outreach 
services, MS India fills gaps in existing service 
availability. These gaps, which MS India address 
through mobile outreach, centre on access to IUDs, 
tubal ligations (TL), and vasectomy. Contraceptive 
1  As cited in the MoHFW, Family Welfare Statistics in India (GOI, 2011) a total of 338,574 TLs and 407,122 IUDs were provided in the state of Rajasthan 
for the period 2010 / 2011 (pp 170-171, tables B8 and B9).
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implants are not yet registered in India, and injectables 
are not offered in public sector facilities. Condoms, 
oral contraceptive pills, and emergency contraception 
are available in public sector facilities (alongside MS 
India provision of PMs and LARC). During government 
stock-outs, MS India supports the public sector by 
supplementing their stock of short-acting methods. 
MS India currently works across Rajasthan, Uttar 
Pradesh and Madhya Pradesh states. In 2011, MS 
India provided a total of 109,074 TLs and 34,091 IUD 
procedures, which contributed to 32% of the total TLs 
and 8% of all IUDs provided in the state of Rajasthan 
in 2011 . [4] Data from client exit interviews 
demonstrates that on average, 80% of MS India’s 
outreach clients were not using a modern family 
planning method before taking up a service through 
outreach.
Study Objectives and Design 
While expanding the availability of family planning 
methods is important, it is equally important that the 
quality of these services is maintained to ensure that 
family planning procedures are safe and meet the 
expectations of clients in outreach settings. Under the 
auspices of the USAID-funded SIFPO-MSI project, 
Population Council carried out an evaluation of MS 
India’s mobile outreach services to provide a better 
understanding of the safety, acceptability, and profiles 
of clients accessing contraceptive services through 
MSI’s outreach service delivery in rural areas. 
Findings from the study will inform and improve further 
family planning outreach programming. 
The study focused on TL and IUD procedures 
provided by MS India in four districts of Rajasthan. 
These methods were chosen as they represent the 
vast majority of MS India’s contribution to the method 
mix of family planning services offered at outreach 
sites. Vasectomy services were excluded from the 
study due to sporadic client numbers. 
Between March and October 2012, 875 women 
receiving a TL and 402 women receiving an IUD 
procedure via MS India outreach were recruited for the 
study. Clients were interviewed before and 
immediately after their procedure at the outreach site, 
and on day 15 post procedure, about their side effects 
and satisfaction. Women who received an IUD were 
also interviewed at day 90 where information was 
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collected about method discontinuation and reasons 
for IUD removal. 
Study Findings and Recommendations 
The study demonstrates that TL and IUD procedures 
can be provided safely and effectively in rural and hard 
to reach areas of Rajasthan through MS India’s mobile 
outreach approach. In the selected cohort no major 
complications were reported and side effects were 
generally mild or moderate. The incidence of side 
effects and complications observed in this study are 
largely in line with published literature.[1,5-10] Most of 
the clients were willing to recommend the service to 
other women, signalling strong client satisfaction. The 
majority of women were from rural areas (81% of TL 
clients; 72% of IUD clients), poor households and had 
no education (53% of TL clients; 30% of IUD clients), 
which shows that through this service MS India is also 
fulfilling its objective in reaching underserved women 
in rural settings. Before taking up a family planning 
method from MS India mobile outreach, 63% of TL 
clients and 41% of IUD clients had never used modern 
contraception.
These findings support the recommendation that, in 
India, family planning programmes should consider 
mobile outreach models to broaden the range of 
services available in rural and hard to reach areas. 
Through mobile outreach, MS India is able to add 
LARC and PMs to the method mix available in 
government facilities, complementing the government-
provided short-acting methods to offer clients a wider 
choice. In addition to service provision, MS India 
should continue to advocate for the registration of 
implants, wider availability of injectables, and promote 
access to a broader method mix in India.
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2.1 Family planning method mix in India 
There is a large unmet need for voluntary family 
planning in India, with an estimated 32 million or 13% of 
currently married women who want to limit their children 
and a further 7% who would like to space the time 
interval between multiple births, but who are not using 
any modern method of contraception. [12] Over recent 
decades, the country has seen a focus, largely driven 
by the GOI, on expanding access to voluntary family 
planning methods including permanent methods (PMs). 
Unique to India, the adoption of female sterilization, 
which has steadily increased over the past two 
decades, tends to occur at a relatively young age 
following early marriage and childbearing, [13] and 
after the birth of at least one son. [2] More than half of 
women who choose a TL have the procedure before 
they reach 26 years of age, and in some states the 
average is as young as 23 years. [2]  
In Rajasthan and more broadly in India, TLs represent 
a significant proportion of the contraceptive method 
mix (see Table 1). Low uptake of LARCs is due to 
multiple factors including weak political commitment 
for these methods, registration barriers, myths and 
misconceptions, and poor provider counselling. 
LARCs, such as IUDs and implants have high levels of 
effectiveness and user satisfaction globally [3, 15] but 
in India only 2% of women use IUDs and none use 
implants (see Table 1). Globally, the IUD has the 
lowest discontinuation rate, compared to other short- 
and long-acting methods of contraception (a review of 
DHS data from 18 developing countries showed that 
the overall discontinuation rate of the IUD was 15.5% 
at 12 months following insertion). Low discontinuation 
can probably be credited to the IUD’s low failure rate 
as well as the necessity to visit a health professional to 
have it removed. [16]
2. Introduction and  
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TABLE 1: Family planning data for Rajasthan State and India
Indicator Rajasthan India
Total fertility rate 3.1 2.5
Contraceptive prevalence rate (CPR) for modern methods (%) 2 55.3 48.0
Female sterilisation 42.6 35.8
IUD 1.3 1.8
Male sterilisation 0.6 1.1
Pill 2.7 3.6
Injection3 0.2 0.1
Condom 7.7 5.5
Traditional methods (withdrawal, periodic abstinence) 2.7 6.4
Total unmet need for family planning 16.9 20.5
Unmet need for spacing births 7.0 7.2
Unmet need for limiting births 9.9 13.3
Maternal mortality ratio (MMR)4 318 per 100,000 live 
births
212 per 100,000 live 
births
2  Source: International Institute for Population Sciences (IIPS). 2010. District Level Household Survey (DLHS-3), 2007-08: India. Mumbai. IIPS.  
3  Source: International Institute of Population Sciences (IIPS) and Macro International. 2008. National Family Health Survey (NFHS-3), 2005-06: 
Mumbai: IIPS and Macro International.
4  Source: RGI, 2011. Special bulletin on maternal mortality in India. SRS Bulletin. Office of Registrar General, Ministry of Home Affairs, India. Accessed 
from http://www.censusindia.gov.in/vital_statistics/SRS_Bulletins/Final-MMR%20Bulletin-2007-09_070711.pdf
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LARC methods offer women the benefit of reduced 
risk of poor maternal and child health outcomes 
resulting from frequent and/ or many births [3] without 
women needing to rely on daily or per-sexual-
encounter action or on re-supply of contraceptive 
commodities. As reversible methods, LARC offer these 
benefits for women who wish to space or delay 
pregnancies. Offering LARC in the context of access 
to TL, vasectomy, and short-acting methods is critical 
to meet the differing needs and preferences of women 
and men, especially as needs may change over the 
span of life stages. Given the myriad of reasons for low 
uptake of LARC and relatively low uptake of short-
acting methods in India, it is necessary to advocate 
and build capacity at multiple levels of the health 
system for a broader method mix and wider choice in 
contraceptive options. 
 
 
2.2  Access to family planning services 
Although the majority of users of modern contraception 
in India are TL adopters (71% nationally and 77% in 
Rajasthan), access to a full range of family planning 
methods, including permanent methods, remains 
limited in under-served areas. Government health 
centres offer condoms and oral contraceptive pills but 
often lack providers with the clinical and counselling 
skills to effectively offer IUDs and do not have 
providers capable of delivering tubal ligation and 
vasectomy procedures. Injectables are not available in 
government facilities and contraceptive implants are 
not registered in India. 
Private (commercial) sector facilities offer a wider 
range of method options, including condoms, pills, 
injectables, IUD and permanent methods. However, 
fees charged in the private sector can pose financial 
barriers for poor clients, and the scarcity of private 
facilities in rural areas limits the private (commercial) 
sector’s ability to address unmet need in these 
regions. 
To address the gaps in access for rural and under-
served populations, the GOI engages in partnership 
with non-governmental service providers as a strategic 
approach to achieving key policy frameworks such as 
the National Population Policy (NPP 2000). Mobile 
outreach by MS India and other non-governmental 
service delivery organisations (e.g. FPAI) to provide 
family planning methods which government is unable 
to offer in rural areas represents an important strategy 
for filling gaps in method access. In Rajasthan, MS 
India is the only organisation providing mobile family 
planning services. The Family Planning Association of 
India (FPAI) implements mobile family planning 
outreach in other states.  
 
 
2.3   Marie Stopes India
Marie Stopes India was established in 2008 to work in 
partnership with the GOI health departments to 
provide reproductive health and family planning 
services to poor men and women living in rural and 
remote areas of Rajasthan, Uttar Pradesh and Madhya 
Pradesh states. In Rajasthan, MS India provides 
outreach services in partnership with the government 
in 11 districts: Jaipur, Ajmer, Alwar, Nagaur, Sikar, 
Rajsamand, Bharatpur, Udaipur, Chittorgarh, 
Banswara, and Pratapgarh. 
Delivering PMs and LARC, MS India complements the 
public sector’s provision of short-acting methods 
offered at government facilities and at the community 
level by community health workers (ASHA, AWW, and 
ANM). In 2011–12, the number of services performed 
by MS India increased and the program has recently 
grown from six to 11 outreach teams covering 372 sites 
operating in eleven districts. In 2011 32% of the TLs 
and 8% of the IUDs provided in the state of Rajasthan 
were obtained from MS India. 
MS India is well-positioned for sexual and reproductive 
health service delivery. As a member of the Marie 
Stopes International (MSI) global partnership, MS India 
promotes and adheres to MSI’s global clinical protocols 
[21], training, monitoring, and standardised quality 
assurance mechanisms.  MS India emphasises client 
focus, meaning that clinical quality, client trust and 
respect, and overall client experience are key. To 
ensure adherence to these standards, MS India 
regularly conducts peer assessments, internal clinical 
audits, and external clinical quality assurance using the 
MSI global monitoring framework, the Quality Technical 
Assistance (QTA). QTA uses a standardised tool to 
assess clinical quality compliance in service delivery 
covering counselling, service provision, infection 
prevention, management of medical emergencies, 
clinical governance, client focus, and management of 
equipment and supplies. For each annual QTA audit, a 
random sample of MS India providers from each 
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service delivery area is assessed. Regular trainings for 
clinical providers ensure that skills are always up-to-
date. 
MS India mobile outreach services are known as 
Clinical Outreach Teams (COT). These seven-member 
teams are comprised of three doctors - a surgeon, a 
medical officer, an anaesthetist (required by GOI) – 
one male and one female nurse, one health care 
assistant, and one driver. In line with the GOI protocol 
only doctors are permitted to provide TLs whereas 
nurses or Auxiliary Nurse Midwives (ANMs) are 
authorized and trained to provide IUD services. The 
COTs provide services in government facilities such as 
primary health centres and community health centres, 
and men and women in the outreach catchment area 
are informed about the services by MS India’s 
Interpersonal Communicators (IPCs) and government 
community health workers known as Accredited Social 
Health Activists (ASHAs). 
Both IPCs and ASHAs are members of the community 
who create awareness of MS India’s outreach services 
and provide information about family planning 
methods. The IPCs and ASHAs also work with the 
government ANMs to mobilise clients at the outreach 
site and to provide follow up care information. As a 
part of the MS India outreach service protocol all 
clients are informed about expected side effects, 
appropriate follow up care, check-up visits with the 
ANM and what to do if they experience any 
complications following their procedure. Both TL and 
IUD clients are also provided with a supply of 
analgesia medicine to take with them post procedure. 
All follow up care is carried out by the government 
ANM who visit clients as informed by the MS India’s 
IPCs. If complications occur beyond the management 
capacity of ANMs and IPCs, clients are referred to 
higher level facilities or a MS India static clinic 
(depending on nature of complication and proximity).  
In 2011, MS India provided a total of 109,074 TLs, 
34,091 IUD procedures amounting to 1,574,781 CYP 
through its outreach programme. Clients choosing 
short-acting methods received their methods through 
the government facility at which outreach took place, 
and are therefore not represented in MS India’s direct 
service provision client numbers. 
MS India adheres to GOI and MSI global clinical 
protocols [21] for all services provided through mobile 
outreach (as well as through MS India’s other service 
delivery channels). This includes comprehensive 
pre-procedure group family planning counselling on a 
broad range of contraceptive methods available in 
India. Clients receive individual counselling to discuss 
method preferences and provide detailed information 
on benefits and possible side effects of the chosen 
method. Client eligibility screening follows MSI clinical 
standards, i.e. pregnancy status, STI screening for IUD 
clients. [21] Clients who are eligible and wish to 
proceed with their LARC or PM sign informed consent 
forms in their local language (Hindi). For clients who 
cannot read or write, the consent form is explained in 
Hindi, and they thumb print their acceptance. TL, 
vasectomy and IUD clinical procedures follow GOI and 
MSI global clinical protocols. All clients receiving TL, 
vasectomy or IUD from MS India are counselled on 
managing post-procedure care and possible side 
effects. Clients are provided with analgesics to take 
home with them for pain management. Clients are 
given the mobile phone number of an MS India clinical 
staff member to contact in case of any complications 
or questions. 
The Marie Stopes International (MSI) outreach model 
In order to increase access to family planning and 
broaden the contraceptive method mix available to 
underserved populations, MSI uses a mobile 
outreach model in over twenty countries to provide 
affordable, high quality family planning services, 
including LARC and PMs, to men and women living 
in rural and hard to reach areas. Sensitisation and 
information provision about the outreach services 
and the different contraceptive methods are 
conducted in advance of the outreach visits, often 
with the assistance from community health workers. 
Outreach teams work in coordination with local 
governments and utilise existing public health 
facilities (or tents where no facilities are available). 
The frequency, with which outreach teams return to 
a location, as well as the duration of each visit, 
depends on the level of demand. MSI mobile 
outreach programmes follow global clinical quality 
standards and implement rigorous follow up systems 
that allow women to access medical advice after 
their treatment. 
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For TL (and vasectomy) clients, MS India contacts 
them by telephone within 48 hours of their procedure. 
This contact is followed up by a visit by a government 
ANM on the third, fifth and 15th day after the 
procedure. All IUD clients receive three visits by a 
government ANM, timed to take place after their first 
post-procedure menstrual cycle, three months post-
procedure, and 12 months post-procedure. No 
additional or different pre- or post-procedure clinical 
protocols were followed for the purposes of this study. 
Rather, participating clients were asked to return to the 
facility where they obtained their service 15 days 
post-procedure for TL clients and 15 days and 90 days 
post-procedure for IUD clients. These additional visits 
were non-clinical and exclusively for the purposes of 
data collection for this study (see section 3.1).  
While expanding contraceptive access and choice is 
very important, it is equally important to maintain 
quality and to ensure that services are safe and meet 
the expectations of clients. MSI has a number of tools 
through which service quality is routinely monitored 
and client experiences and satisfaction is measured. 
To further inform and improve its family planning 
services, a more in-depth service evaluation among 
women receiving TL and IUDs procedures via MSI 
India’s mobile outreach clinics in the state of Rajasthan 
was conducted and originally documented by the 
Population Council in collaboration with MS India for 
the Support for International Family Planning 
Organizations (SIFPO)-MSI project.[17, 18] The 
evaluation measured the prevalence of side effects 
and complications, health seeking behaviours, and 
discontinuation of IUDs, as well as the socio-
demographic profile and satisfaction levels of clients 
receiving these mobile outreach services.  
 
 
2.4  Study aims and objectives 
The overall aim of this service evaluation was to 
provide more understanding about the safety, 
acceptability and profile of clients who access TL and 
IUD procedures via MS India’s mobile outreach in rural 
areas. Through outreach in government facilities, MS 
India fills gaps in access to a LARC and PMs, helping 
ensure a broad contraceptive method mix is available 
to women and men in rural and hard-to-reach areas. 
With contraceptive implants unavailable in India 
(currently not registered) and a significant but irregular 
client volume for vasectomy, this study focuses on the 
provision of TL and IUD, methods that provide women 
with a choice of LARC and PM in rural India. This 
study’s findings will help improve MS India’s provision 
of services as well as inform other organisations 
currently active in outreach service delivery. Specific 
attention is paid to how service quality can be assured 
and key programmatic areas such as counselling 
messages and follow-up care mechanisms can be 
strengthened and replicated.
The evaluation has five objectives:
1.  To measure the prevalence of side effects (and the 
severity of side effects) associated with TL and IUD 
procedures offered in MS India’s mobile outreach 
sites
2. To assess the discontinuation rate at 90 days post 
procedure associated with IUD when delivered via 
outreach services 
3. To explore clients’ health seeking behaviours post 
procedure 
4. To determine the client profile and proportion of 
“poor” clients who receive TL and IUD services via 
MSI India’s outreach services; and 
5. To evaluate clients’ satisfaction with MSI’s TL and 
IUD outreach services.
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3.1  Study design, location and 
participants 
This evaluation involved following a cohort of women 
who received TL and IUD procedures from MS India 
between March and October 2012 at 235 mobile 
outreach sites. The sites were located in four districts 
in the state of Rajasthan (Jaipur, Ajmer, Alwar and 
Naguar) that were purposively selected on account of 
having the highest services numbers for these 
contraceptive services during 2010-2011. 
Women were included in the study if they met the 
following eligible criteria: received TL or IUD via 
outreach services during the study period and were 
willing to give written or verbal informed consent to 
participate in the evaluation in their local language 
(Hindi). Written consent was provided in Hindi and 
verbal consent given (in Hindi) for the minority of 
clients who could not read or write.
The Population Council India office followed the IRB 
submission requirement. This study was exempted 
from full IRB review since it was not a clinical study; 
did not involve vulnerable populations; did not expose 
study subjects to more than minimal risks (e.g., health, 
legal, physical, social, economic, or psychological); did 
not involve voice or video recording. 
Sampling
At the time of the study, a total of five outreach teams 
(Jaipur had two teams) were operating in the four 
districts included in the study and provided both TL 
and IUD services. The sample size was calculated 
separately for TL and IUD procedures to ensure that 
enough clients were recruited for each strata, and were 
divided between the 5 teams until the sample size was 
achieved. 
The following formula was used for calculating the 
sample size, where N is the sample size required for 
the study and  z
1-∝/2
 is the level of confidence taken as 
95%. 
N =                       x deff 
For the TL client sample size, the baseline indicator (p) 
was taken as 3% which was based on findings from 
other studies that documented a range of 1-4% 
complication rate for TL procedures carried out in 
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similar settings [7, 8]. A margin of error (d) of 2%, a 
design effect (deff) of two was used to provide a 
sample size of 745. In addition, a loss to follow up rate 
of 25% was then used to provide an overall sample of 
800 TL clients. 
For the IUD client sample size, the baseline indicator 
(p) for a discontinuation rate after 90 days of 15% was 
used based on an evaluation of MSI outreach services 
in other countries which documented discontinuation 
rates from 2.3 - 20.9%.[9]  A margin of error (d) of 
1.5%, a design effect (deff) of 1.5 provided a sample of 
392. Considering a loss to follow up rate of 25% a total 
of 400 IUD clients was required.
Survey instrument, data collection and data 
analysis 
A research team of two to three female investigators 
and a supervisor to recruitment participants and collect 
data were trained by Population Council. These 
individuals were chosen from the pool of investigators 
and supervisors available in the states who work with 
research organisations as and when they are required 
to collect data. For the purpose of this evaluation, 
investigators were chosen based on their experience 
with the Population Council and their availability during 
the required period. 
Clients were recruited for the study prior to their 
procedure at the outreach site. Following informed 
consent, participating clients were interviewed about 
their background characteristics; knowledge and 
source of information about the outreach services; 
previous use of contraception; and reasons for 
choosing TL or IUD, and for opting to receive the 
service from MS India. After the procedure and post 
recovery at the site, clients were interviewed again to 
obtain feedback concerning satisfaction and any 
immediate side effects associated with the procedure. 
These interviews were conducted privately by 
investigators appointed by the Population Council. One 
of the roles of supervisors was to ensure privacy from 
other clients and from MS India providers and 
government staff. The post-procedure interview took 
no longer than 10-12 minutes so that clients could 
leave without undue delay. 
Both TL and IUD clients were asked to return on day 
15 post-procedure to the facility where they received 
z2
1-∝/2
  p(1-p)
d2
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Level 1: Very mild The client experiences low level of discomfort that does not require any medical 
intervention
Level 2: Mild The client experiences some level of discomfort that only requires resting or 
minimum level of medical intervention such as taking pain relief from a medical 
shop
Level 3: Moderate The client experiences more frequent level of discomfort that requires attention 
from medical personnel, such as a doctor
Level 4: Severe The client experiences frequent level of discomfort that requires either further 
medical check-up or hospitalization
TABLE 2: Severity level of side effects5
MS India services for a follow up interview. The cost of 
travel and refreshments for this interview was met by 
the study. At this visit, the interviewer collected 
information about side effects and any complications, 
care seeking behaviour, resumption of normal 
activities and satisfaction. Women receiving an IUD 
were also asked to return on day 90 when information 
was collected about method discontinuation.  If clients 
did not return to the site for a follow up interview, 
attempts were made to contact respondents by 
telephone if they had agreed. All women were asked in 
Hindi for consent to be interviewed at both day 15 and 
90.
This service evaluation recorded any incident of 
complications during the procedure as indicated in the 
client records and then clients’ experience of any side 
effects immediately after the procedure following their 
recovery period. Later, delayed side effects and 
complications were recorded on day 15. Side effects 
and complications were categorised by type of 
symptom and severity. As the study was conducted at 
outreach locations medical personnel were not 
available to assess or validate the side effects at follow 
up interviews. Therefore, to ensure self-reporting of 
side effects was consistent and simple for respondents 
to recall, the level of severity was measured by the 
type of medical intervention required (if at all) to 
address the problem. The definitions of level of 
7  Adapted from a similar MSI outreach evaluation: Reiss K, Nantayi L, Odong J & Ngo TD. Providing long acting and permanent contraceptives through 
outreach in rural Uganda. MSI, 2012
severity are shown in box 2.  Minor or moderate side 
effects were later differentiated from moderate or 
severe complications to distinguish between expected 
side effects and those that are not expected (and 
possibly related to the procedure or post-operative 
conditions of the woman). 
The study design, development of survey tools and 
data collection was managed by the Population 
Council. Data was entered using the Census and 
Survey Processing System (CSPro 5.0.1). Descriptive 
statistical methods were conducted for analysis to 
provide using the Statistical Package for Social 
Sciences (SPSS 18.0).
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4. Findings
4.1 Study recruitment 
The sample was recruited from women attending 235 
MS India outreach service days based in a variety of 
available facilities in each district, such as primary 
health centres, community health centres and a MSI 
clinic based in Ajmer district. The majority of services 
were delivered in rural locations (81% of TLs and 72% 
of IUDs) with the remaining delivered in urban and 
peri-urban areas (19% of TLs and 28% of IUDs). 
During the study period 1423 clients attended outreach 
services for TL and IUD procedures, and out of these 
women 1277 were eligible to participate in the study. 
Those who were not eligible either could not go ahead 
with the procedure due to medical reasons identified 
during the consultation, or decided not to go ahead 
with the procedure. Table 3 shows the distribution of 
the sample for each of the four districts. All clients 
agreed to take part and as shown in Figure 1, among 
the 1277 study participants 875 received TL, and 402 
had IUDs inserted. At day 15, 803 (92%) of women 
who had received a TL procedure and 369 (92%) of 
IUD clients completed a follow up interview. Of these, 
718 TL clients and 342 IUD clients returned to the 
health facility, and 85 TL clients and 27 IUD clients 
were contacted through a follow up telephone 
interview. Loss to follow up for both TL and IUD clients 
was 8% (72 for TL and 33 IUD). At the 90 day follow-
up for IUD clients, 98% (n=393) of the original enrolled 
clients attended a follow up visit, with only 2% loss to 
follow up (see Figure 1).  
4.2 Socio demographic characteristics  
The median age of clients was 26 years for TL clients 
and 25.5 years for IUD clients. All women were 
married and had one or more children (see Table 4).  
Two thirds of women adopting the TL method of 
contraception were between the ages of 25-29 years 
(67%); whereas the age of women adopting the IUD 
was more evenly spread, with less than one half aged 
25-29 years (47%), and one third 20-24 years (30%), 
and one quarter over the age of 30 years (23%). The 
majority of TL and IUD clients had two children (40% 
and 44% respectively) before adopting their method of 
contraception; followed by one third (36%) of TL clients 
and one quarter (22%) of IUD clients having three 
children. 
The majority of clients were Hindu (TL: 94% and IUD: 
85%) and belonged to disadvantaged groups classified 
in India as Other Backward Classes6 (TL: 53% and 
IUD: 62%). One quarter of both TL (29%) and IUD 
(24%) clients were from Schedule Caste / Schedule 
Tribe. A large proportion of women had never been to 
school or only had primary education (TL: 69% and 
IUD: 47%); and considerably more women opting for 
IUD than TL had achieved secondary or higher 
education (53% and 31% respectively). The majority of 
women were housewives (TL: 75% and IUD 84%), with 
more women having a TL than IUD being a farmer or 
agricultural labourer (19% and 8% respectively). 
To assess the socio-economic status and poverty 
levels of women the study adopted the Standard of 
Living Index (SLI) that is widely used in other national 
surveys of India and therefore the results are 
comparable to similar population based surveys for the 
state of Rajasthan7.  This method is based on 
assigning a measure for the household’s type of toilet 
facility, source of lighting and drinking water, type of 
fuel for cooking and ownership of durable goods. The 
scores are then added up to produce an overall index 
that ranges from a low, medium and high SLI score. 
The low SLI is categorised as “poor”. 
More than half of TL clients belonged to households 
categorised as either low (25%) or middle income 
(32%) SLI. By comparison, most IUD clients belonged 
to households with a high SLI (61%) and reported a 
slightly higher average monthly household income - of 
Rs 8,516 RS (US$155) - than TL clients at Rs 7,400 
(US$148). 
6  Other Backward Classes is a collective term, used by the Government of India, for castes other than scheduled castes and scheduled tribes, which are 
higher on social hierarchy than SC/ST but educationally and socially disadvantaged.
7  Such as the National Family health Surveys (NFHS) and District Level Household Surveys (DLHS) published by the International Institute for Popula-
tion Sciences and ORC Macro.
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FIGURE 1: Study cohort profile
1423 women registered for outreach services 
(TL 976 & IUD 447)
1277 eligible clients to participate
Loss to follow up: 
TL 72 (8%); IUD 
33 (8%)
Loss to follow 
up (of original 
enrolled): IUD 9 
(2%)
875 tubal ligation 402 IUD
Not eligible: TL 
101 (10%); IUD 
45 (10%)
803 tubal ligation  
(92%)
369 IUD  
(92%)
393 IUD  
(98%)
Day 1
Day 15
Day 90
District Tubal ligation clients  % (n) IUD clients %(n)
Ajmer 28.0 (245) 10.4 (42)
Alwar 16.9 (148) 40.3 (162)
Jaipur 28.7 (251) 38.1 (153)
Nagaur 26.4 (231) 11.2 (45)
Total 100.0 (875) 100.0 (402)
TABLE 3: Distribution of TL and IUD clients recruited for the study by district
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TABLE 4: Client socio-demographic characteristics for TL and IUD services
Socio-demographic characteristics Tubal ligation clients 
(n=875) % (n)
IUD clients  
(n=402) % (n)      
Age of women                              [mean] 26.0 25.5
Under 20 (15-19) - 0.2 (1)
20-24 17.1 (150) 29.9 (120)
25-29 67.3 (589) 46.8 (188)
30+ 15.5 (136) 23.1 (93)
Number of living children [mean] 2.9 2.6
1 0.5 (5) 15.2 (61)
2 40.0 (350) 43.5 (175)
3 36.2 (317) 22.1 (89)
4 or more 23.2 (203) 19.1 (77)
Religion
Hindu 93.9 (822) 84.8 (341)
Muslim 5.9 (52) 14.7 (59)
Other religious group 0.1 (1) 0.2 (2)
Caste 
Schedule caste/ Schedule tribe 29.0 (254) 23.7 (95)
Other backward classes (OBC) 53.1 (465) 61.7 (248)
General 17.8 (156) 14.6 (59)
Education
Never attended school 52.5 (459) 30.1 (120)
Primary education (class 1-5) 16.8 (147) 16.9 (69)
Secondary education (class 6-9) 22.4 (196) 36.3 (146)
Higher education (class 10 and above) 8.3 (73) 16.7 (67)
Occupation
Housewife 74.9 (655) 83.8 (337)
Farmer / agricultural laborer 19.2 (168) 7.7 (31)
Other / petty business / laborer / community health worker etc. 5.9 (52) 8.5 (34)
Standard of living index
Low 24.7 (216) 14.2 (57)
Medium 31.7 (277) 24.4 (98)
High 43.7 (382) 61.4 (247)
Average monthly household income Rs. 7400 (US$ 148) Rs. 8515.71 (US$ 155) 
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4.3  Knowledge and source of 
information about contraception
Knowledge about contraceptive methods was quite 
high among both TL and IUD clients, although the 
mean number of modern methods known was higher 
among IUD clients than for TL (4 and 2.8 respectively). 
Most commonly cited methods for TL clients were TL, 
condom and pill, with lower awareness of other LARCs 
and PM methods such as IUD, DMPA and vasectomy. 
Women who received an IUD expressed a wider 
knowledge of other contraceptive methods. The main 
sources of information about contraception for both TL 
and IUD clients were from Auxiliary Nurse and 
Midwives (ANMs), community based health workers 
(ASHA and Anganwadi workers [AWW]), husbands, 
and MSI IPC. 
4.4  Previous contraceptive use
The majority of women were not using a contraceptive 
method before joining the study:  73% (n=639) of TL 
and 54% (n=217) of IUD clients. Out of the 236 TL 
clients who reported currently using a contraceptive 
method only 86 (36.4%) could report how long they 
had been using the method. It is also unknown what 
type of family planning method (modern or traditional) 
was being used. Prior to adopting a LARC or PM at the 
MS India outreach service, 37% (n=325) of TL clients 
and 59% (n=236) of IUD clients reported having used 
contraception in the past. This finding implies that 63% 
of TL clients and 41% of IUD clients were new 
adopters of contraception.
4.5  Source of information about 
outreach services and decision making  
The majority of women learnt about MS India outreach 
services from the facility based health workers or 
community health workers such as ASHA, AWW and 
ANM (TL 78%; 56% IUD). A lower proportion of 
women learnt about the outreach services from the 
MSI IPCs with 25% (n=217) of TL clients and 27%, 
(n=108) of IUD clients reporting that they had been 
contacted by the IPC in the community. 
It is quite common for community health workers such 
as ASHAs to initially approach other family members 
when raising awareness about the outreach service as 
the decision to adopt family planning is strongly 
influenced by the husbands and parents-in-law. When 
there is agreement to consider family planning, women 
are then approached to discuss the services available. 
FIGURE 2: Reasons cited for choosing MSI outreach services - IUD and TL (% of women)
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Free service
Doctors are available
Husband decision
Other family member decision
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The main reasons cited by women for choosing the 
MSI India’s outreach services were because the 
services were free (77%, n=673 for TL and 73%, 
n=291 for IUD), followed by the fact that clinical staff 
were available (60%, n=521 and 57%, n=228), (see 
Figure 2).   More than half of IUD clients (54%, n=217) 
compared to one third (36%, n=315) of TL clients said 
their husband’s recommendation was the reason they 
used the service, and for women seeking a TL service 
one third also said they were recommended by another 
family member (34%, n=293). Other reasons cited for 
choosing the outreach services were: financial 
reimbursement for travel costs, a better facility than 
alternative facility, proximity to home, and no other 
service available. 
Reasons for choosing TL and IUD 
methods 
There was much variation between the reasons cited 
by women for adopting TL and IUD methods of 
contraception (see Figure 3). Women were able to give 
multiple answers to why they chose their respective 
family planning method. The main reason for adopting 
TL was due to having reached a desired family size 
(81%, n=707) and for IUD the majority of women said 
their husband’s preference for this method influenced 
their decision to use it (68%, n=274). Influence of the 
husband or another family member on the woman’s 
decision making was also commonly reported for 
reasons to adopt TL (48%, n=420 and 38%, n=335 
respectively). Nearly half of IUD clients also said the 
influence of community health worker counselling and 
having reached their desired family size were why they 
chose the long acting method (45%, n=183 and 43%, 
n=173). One third of TL clients (39%, n=341) also 
reported that they chose to be sterilised as their 
husbands did not agree to have a vasectomy.   
 
 
4.6 Side effects and incidence of 
complications 
Side effects on the day of the procedure were 
assessed from the clinical records to identify the types 
of side effects or complications that occurred during 
the procedure and post-procedural phase. Side effects 
on day 15 for both TL and IUD clients, and day 90 for 
IUD relied on the clients self-reporting of symptoms 
and level of severity.   
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Completed family size
Influenced by husband
Influenced by family member
Believe TL safer than vasectomy
Husband not want vasectomy
Influenced by health worker
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FIGURE 3: Reasons cited by clients for adopting tubal ligation and IUD – multiple answers given (% of women)
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Day of Procedure
Information from clients’ records showed that among 
875 TL procedures, pain was recorded for 4% (n=32) 
at the time of the procedure. During the post operation 
observation period, pain was recorded for 10% (87), 
followed by vomiting (0.3%, n=3) and fever (0.1%, n=1) 
among TL clients.  Among the 402 IUD procedures 
pain was recorded in 5% (n=20) of cases and 
dizziness (0.5%, n=2) at the time of insertion. No 
incident of complications related to both TL and IUD 
surgical operations at the time of the procedure or 
immediately afterwards were identified.
Following the procedure, 35% (n=308) of TL clients 
and 32% (n=94) of IUD clients reported experiencing 
side effects immediately after adopting their method 
(see Table 5). The majority of women experienced pain 
(34% and 22% for TL and IUD clients respectively), 
with 12% of TL clients reporting severe pain. One TL 
client also reported severe bleeding post procedure, 
but this case was managed by the outreach team and 
was not classified as a major incident.
TABLE 5: Types of side effects and severity reported by clients post procedure
Side effects Tubal ligation 
clients  
(n=875) 
% (n)
IUD clients    
(n=402)  
% (n)
  
Pain 34.4 (301) 22.1 (89)
Very mild 14.7 (129) 16.6 (67)
Mild 16.2 (142) 4.2 (17)
Moderate 1.4 (12) 0.7 (3)
Severe 2.1 (18) 0.5 (2)
Bleeding 4.5 (14) 1.2 (5)
Very mild 1.3 (11) 0.4 (2)
Mild 0.2 (2) 0.7 (3)
Moderate - -
 Severe 0.1 (1) -
Other (vomiting, dizziness, weakness) 0.6 (5) -
Total women reporting any side effects 35.5 (308) 32.4 (94)
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Day 15 post procedure 
On day 15, study participants were requested to return 
for an interview by the Population Council research 
team. This visit is separate from the routine follow-up 
and check-up by conducted by MS India and 
government providers that is carried out in the 
community (client’s home). Information was obtained 
regarding the types of side effects women were 
experiencing at day 15. Women could list multiple side 
effects. Among the women who had a TL who were 
interviewed (n=803) 15% (n=119) reported at least one 
type of side effect, and for those who had an IUD 
(n=369) 21.4% (n=79) said they were still experiencing 
some side effects. 
Tubal ligation: As on the day of procedure pain was 
reported most frequently (7%, n=54) by TL clients, 
followed by abdominal pain (6%, n=50) (see Table 4).  
Fewer women experienced problems with the wound 
(1%, n=10), and less than 1% reported bleeding from 
the wound, urinary problems and a blood clot. At day 
15 the majority of side effects were identified as minor 
with the majority able to seek medical care. A total of 
31 women reported at least one moderate side effect 
(4%) and one woman (0.1%) had a serious 
complication and required hospitalization for one day 
due to bleeding from the wound and infection. Out of 
the 119 women who reported any side effect, the 
majority experienced very mild or mild levels of 
severity (61%, n=72). Less than 4% (n=32) out of 803 
TL clients reported a moderate or severe level of 
complication which required medical attention.
IUD: The most commonly reported side effects were 
pain (11%, n=42) and bleeding (11%, n=41) up to day 
15 after IUD insertion (see Table 7). Five percent 
(n=18) experienced abdominal swelling and / or pain, 
and less than one percent (n=2) complained of having 
a urinary problem.  One woman experiencing 
prolonged bleeding said that she was going to get the 
IUD removed. Compared to TL, which involves a (small 
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TABLE 6: Types of side effects / complications and severity reported by TL clients 15 days post procedure (n=803)
Side effect  / 
complication
Level of severity %(n=803)
 
Total
%(n)
Very mild
%(n)
Mild
%(n)
Moderate
%(n)
Severe
%(n)
Pain in the wound 2.8 (23) 1.0 (7) 3.0 (24) - 6.7 (54)
Abdominal pain 2.9 (24) 2.0 16 1.2 (10) - 6.2 (50)
Wound did not heal / 
infection
0.7 (6) 0.2 (2) 0.2 (2) - 1.2 (10)
Wound oozing blood 0.1 (1) 0.1 (1) 0.1 (1) 0.1 (1) 0.5 (4)
Urinary problem 0.1 (1) - 0.1 (1) - 0.2 (2)
Blood clot 0.1 (1) - - - 0.1 (1)
Total number of 
complications 
56 26 38 1 121
Total women 5.8 (47) 3.1 (25) 3.8 (31) 0.1 (1) 14.8 (119)
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and quick) surgical procedure, IUD insertion does not 
require a surgical procedure and is therefore 
considered less invasive. However, a higher proportion 
of IUD clients reported severe side effects, such as 
pain, bleeding and abdominal pain (1%, n=4). Three 
women (1%) reported that their IUD had come out by 
day 15.  Among the 79 women who reported any side 
effects, the majority experienced very mild or mild 
level of severity (76%, n=60), and 24% (n=19) said 
their side effects were moderate or severe and 
required medical attention. In total 5% (n=19) out of 
369 IUD clients reported a moderate or severe level of 
side effect which required medical attention.
4.7 Follow up care and health seeking 
behaviour by day 15 
At the day 15 follow up interview women were also 
asked if they had sought medical care / advice or 
self-medicated in response to any of the side effects 
TABLE 7: Types of side effects / complications and severity reported by IUD clients 15 days post procedure (n=369)
Side effect  / 
complication
Level of severity %(n)
 
Total
%(n)
Very mild
%(n)
Mild
%(n)
Moderate
%(n)
Severe
%(n)
Pain 5.7 (21) 2.4 (9) 2.4 (9) 0.8 (3) 11.4 (42)
Bleeding (menstrual) 6.2 (23) 1.6 (6) 2.7 (10) 0.5 (2) 11.1 (41)
Abdominal swelling / 
pain
3.5 (13) 0.5 (2) 0.5 (2) 0.3 (1) 4.9 (18)
Urinary problem 0.5 (2) - - - 0.5 (2)
IUD expulsion 0.8 (3)
Total complications 
reported
59 17 21 6 103
Total women 12.0 (45) 4.0 (15) 4.0 (15) 1.0 (4) 21.4 (79)
they had experienced. This question was asked to all 
women regardless of what level of severity of side 
effects they had experienced (which is also based on 
the level of intervention sought to help address these 
symptoms), in order to determine where these women 
went for medical care. 
5% of TL clients and 8% of IUD clients sought further 
medical care in addition to the follow up care advice 
and pain relief medication they were given as they left 
the outreach service. Among those TL and IUD clients 
who had reported any side effects and / or 
complications (n=119 and n=87 respectively), one third 
of both TL clients (34%, n=41) and IUD clients (32%, 
n=28) sought medical attention. The majority of women 
went to a government health centre for follow up care, 
followed by the MSI clinic for IUD clients and ANM and 
MSI IPC for TL clients. Although it is not known what 
medications were purchased, a smaller number of 
clients self-medicated by buying medicines from 
pharmacies / drug shops or visiting a private clinic  
(see Table 8). 
8  In the level of severity definitions applied to measuring side effects a “mild” level could also include if a woman needed to self-medicate by buying pain 
relief from a pharmacy or drug store.  Note that levels moderate and severe included seeking medical care from a health provider such as a nurse, 
private clinic or hospital. 
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TABLE 8: Health seeking behaviour among women up to day 15 following TL and IUD procedure
Health seeking behaviour Tubal ligation clients  
(n=803) % (n)
IUD clients    
(n=369) % (n)
Did not seek care 94.8 (762) 93.0 (341)
Self medicated 0.8 (7) 1.3 (5)
Government HC / hospital 2.8 (23) 3.7 (14)
Private clinic 0.3 (3) 0.5 (2)
MSI clinic (static clinic) 0 1.8 (7)
Others (ANM, MSI IPC) 0.9 (8) 0
Total women sought care / advice 5.1 (41) 7.5 (28)
Resumption of normal activities and work 
Among TL clients 94% (n=757) reported that they 
returned to work by the 15th day following their 
procedure. Being able to return to work for IUD clients 
was slightly more rapid than TL clients with 96% 
(n=359) resuming their normal activities by day 15. 
Approximately 4% of women reported that they could 
not return to work for an average of 20 days. 
4.8 IUD discontinuation by day 90 post 
procedure 
During the follow up visit on day 90 IUD clients were 
asked about removal or expulsion of their IUD. Out of 
the 393 IUD clients who were interviewed at day 90, 
92% were still using the method.  Thirty two women 
(8%) who attended the follow up interview on day 90 
had discontinued their IUD (see Figure 5).  Of these 32 
women, 16% (n=5) reported that their IUD had been 
expelled and 84% (n=27) had had their IUD removed. 
Of the women whose IUD had come out, three of these 
women had reported the expulsion of their IUD at the 
time of the day 15 interview. The majority of women 
had their IUD removed at the health centre where the 
outreach services was carried out (48%, n=13); others 
sought their removal from a private nurse or doctor 
(41%, n=11) and a public health facility (7%, n=2). One 
woman had removed the IUD by herself.
Women gave multiple reasons for wanting to have the 
IUD removed after 3 months. Out of the 27 women, the 
main reason given for removing their IUD was due to 
bleeding (n=27), feeling weak (n=19), discomfort during 
intercourse (n=6), husband objected (n=4), fear the 
IUD may have moved inside the body (n=3), fear will 
cause cancer (n=3), and wanted to have another child 
(n=1). There was also one report of IUD failure with 
one woman getting pregnant and consequently getting 
the device removed. 
Among the women who decided to have their IUD 
removed or expelled (n=32) and still did not want to get 
pregnant, only 15 women switched to an alternative 
method by day 90. Methods that these women started 
to use were TL (n=5), contraceptive pill (n=7) and 
condom (n=3).   
Side effects reported at day 90 post 
procedure 
Just over half of women (54%, n=195) who still had 
their IUD when interviewed on day 90 said they did not 
experience any side effects or continuing problems 
associated with their IUD. Out of the women who did 
report side effects (46%, n=166), the most frequently 
reported problem was menstrual bleeding problems 
and abdominal pain (see Figure 6). 
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FIGURE 4: Flow chart showing IUD discontinuation by day 90 among IUD study cohort
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FIGURE 5: Self reporting of continued side effects of IUD at day 90 (% of women) (n=393)
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4.9 Client Satisfaction  
Client satisfaction was recorded at day 15 and day 90 
among IUD clients. Overall satisfaction with the 
outreach service was the same for both groups of 
women accessing TL and IUD services, with 98% of 
clients saying that the quality of services they received 
was either as expected or better than expected. 1.5% 
(n=6) of IUD clients were dissatisfied with the service 
due to the attitude of the doctor. Reasons cited by the 
small number of TL clients who were not satisfied with 
Findings
the service included lack of transport to the site, no 
provision of blankets and insufficient financial 
compensation for travel.  
Women were also asked on the day of the procedure if 
they would recommend the method they received to a 
friend: 91% (n=792) of TL clients said they would 
recommend TL to a friend and 86% of IUD clients 
(n=345). On day 90 the proportion of women who said 
they would recommend the IUD method to a friend 
decreased to 83% (n=326). 
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The study has shown that MS India provides TL and 
IUD contraceptive methods safely and effectively via 
mobile outreach in rural areas of Rajasthan, with low 
levels of minor complications and discontinuation, and 
a high level of user satisfaction. Furthermore the 
results indicate that MS India’s outreach services are 
reaching under-served populations and addressing the 
contraceptive unmet needs of poor and marginalised 
men and women in the state of Rajasthan, with the 
majority of TL and IUD clients living in rural areas (81% 
and 72%), having never attended school (53% and 
30%), and belonging to disadvantaged groups 
(classified in India as Other Backward Classes; 53% 
and 62%).  Although the findings showed that the 
majority of TL and IUD clients came from households 
with a high SLI (TL 44% and IUD 61%), the proportion 
of TL clients who have a low SLI (25%) is comparable 
to the proportion of the population in Rajasthan who 
are of low income level households (26%)9.[12]  A 
higher proportion of TL clients than IUD clients are 
from households with a low or medium SLI (56% and 
39%). Prior to receiving LARC or PM via outreach 
services, 73% of TL clients and 54% of IUD clients 
were not using any form of contraception, and 63% of 
TL clients and 41 % of IUD clients had never used 
contraception before. The study did not collect data on 
what method those using contraception had been 
using prior to receiving their LARC or PM method. The 
majority of women choosing to have a TL had two to 
three children (76%) and the majority of IUD clients 
had one to two children (59%) demonstrating the 
importance of expanding contraceptive choices for 
women in hard to reach areas who wish to space as 
well as limit the number their number of births. 
Women learn about contraception mainly from the 
government ANM, spouses or community health 
workers. While a majority of women were able to name 
family planning methods, the study did not measure 
their level of understanding of these different methods, 
which is a limitation. Knowledge of IUDs was low, and 
the fact that 22% of IUD discontinuations were related 
to myths and misconceptions around IUDs (for 
example causing cancer or moving in the body) 
demonstrates the need to provide more 
comprehensive information about this method. 
The main decision women gave for visiting MS India’s 
outreach sites were because these services were free 
5. Discussion and 
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and medical personnel were available. A large 
proportion of women also reported the influential role 
of their husbands or other family member in their 
decision to adopt a TL or IUD. This highlights the 
important role these people play in women’s 
contraceptive decision making and the need for 
outreach services to fully incorporate them in 
educational activities to ensure both men and women 
are fully informed about all contraceptive methods 
available.   
 
 
Incidence of side effects and 
complications 
 
The reported incidence of side effects and 
complications in this study are not dissimilar to those 
documented in the published literature. One third of all 
women who had an IUD fitted said they experienced 
some side effects following their procedure (32%, 
n=94).  Side effects experienced by women following 
insertion of an IUD were generally mild to moderate 
with less than 1% (n=2) reporting severe pain. At day 
15, one in four women who had an IUD fitted (23%, 
n=87) reported still experiencing at least one type of 
side effect, with 1% (n=4) reporting a severe 
complication relating to pain, bleeding and abdominal 
pain / swelling.  According to the literature, 
complications during IUD insertion, such as cervical 
laceration or uterine perforation are rare. [5, 15] 
However, most women experience some minor side 
effects such as changes in menstrual cycle and pain. 
In a similar study conducted in 2010 by MSI among 
clients receiving LARCs and PMs in outreach settings 
in Uganda, it found 3% of IUD clients experience 
severe side effects immediately after insertion and 
1.9% experiencing minor complications at day 15. [6] 
In another study carried out in 2009 in a clinical 
setting, 9% of the 1,947 participants reported serious 
pain in the first nine weeks of IUD use. [19] In this 
study, even though the cases were not verified by a 
medical practitioner, they highlight important areas to 
be addressed.
One third of women who adopted a TL also 
experienced side effects following their procedure 
(35%, n=308) with the majority being described as mild 
to moderate, and 2% (n=18) reporting severe pain.  At 
day 15 following the procedure, 15% (n=119) of TL 
9  As documented in the DLHS3, for 2007-2008 survey the SLI index for the state of Rajasthan was low 25.5%; medium 29.5%; and high 28.8%. 
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clients reported still experiencing at least one type of 
side effect.  Studies have shown that TL is generally 
associated with low levels of minor complications 
(1-4%), such as wound infections and small 
haematoma which can be resolved easily and rapidly. 
[10]  For example, in the same study cited above 
among MSI clients receiving LARCs and PMs in 
outreach settings in Uganda, it found 1% of TL clients 
experienced minor complications at the day 15 follow 
up interview and a further 6% experienced frequent 
pain.[6]  In this study, 13% (n=118) of TL clients 
reported very mild-moderate complications at day 15 
and only 0.1% (n=1) reported severe complications 
related to bleeding at the site of the wound.  
 
 
IUD discontinuation 
 
All IUD insertions were interval insertions. In the 
current study a total of 8% (n=32) of IUD clients had 
discontinued their IUD at day 90. Of these women 1% 
(n=5) reported their IUD had been expelled. This is 
comparable with other published studies that have 
shown the proportion of women experiencing 
expulsion of the IUD ranging from less than 1% to 10% 
annually, although it is reported that most of these 
occur within the first three months. [5, 11] There is 
evidence to suggest that correct insertion technique 
can reduce the rate of expulsion. [5]
A relatively small proportion, 7% (n=27) of women 
decided to have their IUDs removed by day 90. 
However this removal rate is slightly higher than that 
reported in other studies conducted in similar non-
clinical settings: the MSI outreach LARCs and PM 
study in Uganda found an IUD removal rate of 6% at 
90 days; [6] and the results of a retrospective multi-
country study assessing discontinuation rates of IUDs 
revealed  3% and 5% of IUD clients had IUDs removed 
within three months in Pakistan and Myanmar 
respectively.[9]  In this study, women who had their 
IUD removed said they did so due to bleeding (n=27), 
feeling weak (n=19) or discomfort and pain (n=6).  
Among the women who discontinued their IUD only 
half of these women switched to an alternative method 
of contraception which highlights the need to have 
mechanisms in place for appropriate follow up and 
counselling for alternative methods. One case of 
method failure was reported; the woman became 
pregnant with her IUD in situ and therefore had it 
removed. This case was recorded in the 90 day follow 
up.  
It may be possible to reduce discontinuation by 
strengthening counselling so that women are aware of 
expected side effects and are informed that these 
should dissipate over time. Expected side effects 
should be clearly distinguished from those that are not 
expected, are serious and require women to seek 
medical help. Qualitative interviews among the IPC 
also revealed that the prevailing myths and 
misconceptions about the safety and efficacy of the 
IUD (and vasectomy) - such as the IUD causing 
cancer, or that it can float around the body, and that 
vasectomy is unsafe for a man - are a barrier for men 
and women to adopt these methods. Campaigns could 
be developed to dispel these myths and increase 
uptake and continuation of this effective method.  
Despite MS India’s standard follow up care process, 
including visits by the government ANM and provision 
of pain relief and other medication, one third of TL and 
IUD clients who reported side effects (TL n=38; IUD 
n=28) still required post procedural care and resorted 
to seeking further medical advice or self-medicated to 
treat their on-going side effects.  Post procedure follow 
up care services may need to be reviewed to ensure 
that the provision of personnel and supplies are 
consistently available in all outreach areas. 
High client satisfaction ratings among TL and IUD 
methods and a willingness of women to recommend 
the outreach services to others are encouraging. 
Satisfaction among users of IUD declined slightly from 
day 15 to day 90 which may indicate a need for more 
counselling regarding the duration of some expected 
side effects.  
 
 
Limitations of the study 
 
This service evaluation has several limitations. 
1.  The SLI used in this study is based on different 
measures of poverty from the tool used in the MSI 
Exit Interview Survey (used across the MSI 
partnership). While this provides a sufficient 
measure in the India context it does not provide a 
reliable comparison with other MSI programmes or 
other poverty data routinely collected by MS India. 
The data in this survey shows MS India reaching 
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women of more high income level households 
which is at odds with MSI data that demonstrates 
that a higher proportion of clients are poor. This 
may be more a reflection of the different definitions 
and methods used to determine “poor” than to 
suggest the clients included in this study are of a 
different socio-economic status than the usual 
profile of MS India’s outreach programme in 
Rajasthan.  
2. Types of side effects and severity of side effects as 
well as IUD expulsion were self-reported and not 
verified by medical personnel, which may have 
resulted in some over reporting. However, these 
self-reports reflect the actual experiences of 
women and should be not be underestimated in 
efforts to improve counselling and awareness 
raising activities around long acting reversible and 
permanent contraceptive methods. 
3. The follow up period of 15 days and then 90 days 
for IUD was relatively short, and therefore the study 
does not provide a good reflection of longer term 
side effects, such as changes in menstrual 
bleeding which may emerge over time, or of 
discontinuation behaviours over a longer term.  It 
would also have been informative to have recorded 
the actual number of days it took both TL and IUD 
clients to recover and resume their normal activities 
to further verify the severity of side effects and 
impact on women’s lives.  
4. Due to the small sample size (related to the 
duration and available resources for the study) it 
was not possible to further analyse the 
characteristics of women who did experience 
complications and discontinued their IUD. As with 
other prospective studies measuring post 
procedure outcomes, without strict medical 
verification and control, it is difficult to differentiate 
side effects / complications as a result of the 
procedure from symptoms relating to the clients’ 
conditions or living environment that may 
exacerbate complications, such as post procedure 
wound care. Therefore for this study it is difficult to 
determine the exact cause of the (small) number of 
complications. 
5. Clients were asked about satisfaction with the 
service in general but not specifically about 
different aspects of the service such as 
consultation, counselling, procedure, pain 
management and recovery, nor about satisfaction 
with the particular method adopted. 
5.1  Conclusions  
 
The study demonstrates the safety and effectiveness 
of providing TL and IUDs through MS India’s mobile 
outreach services in the state of Rajasthan, and the 
importance of continuing to use this service model to 
increase access and choices for poor men and women 
living in rural areas. By providing TLs and IUDs in 
underserved, hard to reach areas, MS India 
significantly contributes to the improvement of 
Rajasthan’s overall sexual and reproductive health 
service provision. This service evaluation has also 
helped to identify areas to strengthen and improve MS 
India’s outreach model, as well as to be considered by 
other mobile outreach programmes. 
5.2  Recommendations 
 
It is recommended that the MS India program consider 
the following: 
•  Strengthen counselling to increase client 
awareness of expected side effects of LARCs and 
PMs to help reassure new-users of these 
symptoms, how to manage them and to emphasise 
that these will dissipate in time. Counselling also 
needs to clearly distinguish between expected and 
unexpected side effects of LARCS and PMS and to 
more clearly outline what to do if complications 
arise. This can help to reduce women seeking 
unnecessary medical care and to ensure women 
have sufficient information on likelihood and 
duration of side effects to make an informed 
decision to continue with or discontinue their IUD. 
•  To address some of the factors cited by women 
who had their IUD removed, as well as to 
encourage other women to adopt this effective, 
reversible method of family planning, the program 
could benefit from conducting further qualitative 
research to explore the myths surrounding long-
acting reversible methods and develop campaigns 
to try to dispel misconceptions and increase uptake 
and continuation. 
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•  All awareness raising activities for outreach 
services and counselling about LARCs and PMs 
need to acknowledge and involve the role of the 
husband and other key family members who 
influence women’s decision making about family 
planning. Whilst informed consent is that of the 
woman’s it is important that close family members 
are well informed about all contraceptive methods 
available as well as post-procedure care. 
•  MS India should continue to monitor the clinical 
outcomes of TL and IUD clients attending outreach 
services including monitoring contraceptive 
compliance so that women who are considering or 
have already had the IUD removed due to side 
effects, and who still have an unmet need, receive 
additional counselling to help them deal with their 
symptoms better or alternatively are offered a 
different method of contraception.
•  Continue to provide supportive clinical supervision 
to outreach teams and review post-procedure 
counselling and care. In particular, ensure clients 
are provided adequate analgesic medication 
following the procedure and understand how to 
check if their IUD is in place.
•  Continue to establish and maintain important 
networks with other health providers who are able 
to address complications and side effects 
effectively. 
•  As a reproductive health right for all women MS 
India should continue to advocate for the 
registration of implants in India and the expansion 
of access to contraceptive injectables in the public 
sector, to enable women to have more choice of 
family planning methods.
 
5.3  Evidence to Action: Marie Stopes 
India response to recommendations 
 
Following the evaluation of MS India’s outreach 
services which were conducted by the Population 
Council in India in 2012, MS India have incorporated a 
number of the recommendations into routine 
programming in order to improve access and quality of 
the outreach services:
•  In order to strengthen all aspects of counselling on 
all methods, an intensive three day training for all 
the field level staff was facilitated and concluded. In 
addition, the recommendation to increase 
awareness among clients of expected side effects 
of LARCs and PMs has been taken on board, with 
additional focus on this area during provider 
training. To improve post procedure counselling 
and follow up, a new system has been instituted 
that ensures a 24 hour follow-up. The nurses in the 
clinical outreach teams have been provided with a 
mobile handset to ensure that the calls are made 
en-route to the outreach site the following day. This 
follow-up ensures that the team is better connected 
with the clients, and helps them understand any 
issues that they may have with the method 
provided. Post procedure counselling is also being 
strengthened through a mobile phone SMS-based 
project, currently being trialled with SIFPO-MSI 
funding, which gives consistent and systematic 
reminders to the nurses to improve post procedure 
care and counselling.
•  MSI has evolved its approach to outreach to 
include the sub-health centre level, so that IUD 
services are now available at the sub centre level.  
Readier access to IUD services has increased 
uptake.
•  All doctors and the nurses have also been trained 
on IUD insertions to ensure quality services.
•  Internal audits to assess quality of services 
provided at all outreach sites have now been 
systematically rolled out.  Every team is reviewed 
once a quarter by the technical quality team. 
MS India continues to work to ensure that the safety 
and effectiveness of its outreach programme is 
expanding choice and access to contraception for poor 
men and women living in rural and hard to reach areas 
of India. 
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